Keyword Analysis & Research: magenta therapeutics

Keyword Analysis


Keyword CPC PCC Volume Score Length of keyword
magenta therapeutics0.490.324186620
magenta0.230.47220427
therapeutics1.290.932806212

Keyword Research: People who searched magenta therapeutics also searched

Keyword CPC PCC Volume Score
magenta therapeutics0.50.466962

Search Results related to magenta therapeutics on Search Engine

  • Home - Dianthus Therapeutics

    dianthustx.com

    https://dianthustx.com/

    WebIn May 2023, Dianthus announced a merger agreement with Magenta Therapeutics and upon completion of the merger, the combined company is expected to operate under the name Dianthus Therapeutics, Inc. and trade on …

    DA: 93 PA: 55 MOZ Rank: 89

  • Magenta Therapeutics Announces Completion of Merger with

    globenewswire.com

    https://www.globenewswire.com/en/news-release/2023/09/11/2741020/0/en/Magenta-Therapeutics-Announces-Completion-of-Merger-with-Dianthus-Therapeutics-and-Implementation-of-Reverse-Stock-Split.html

    WebSep 11, 2023 · Magenta Therapeutics Announces Completion of Merger with Dianthus Therapeutics and Implementation of Reverse Stock Split. The combined company will operate as “Dianthus Therapeutics, Inc.” with...

    DA: 18 PA: 90 MOZ Rank: 57

  • Days after halting leukemia drug, Magenta moves to close its doors

    fiercebiotech.com

    https://www.fiercebiotech.com/biotech/days-after-halting-leukemia-drug-magenta-moves-close-its-doors

    WebFeb 2, 2023 · Biotech. Days after halting leukemia drug, Magenta moves to close its doors. By Annalee Armstrong Feb 2, 2023 5:06pm. Magenta Therapeutics Emerging Biopharma strategic options drug...

    DA: 23 PA: 72 MOZ Rank: 44

  • Magenta's C-suite heads out the door with 85% of staff - Fierce …

    fiercebiotech.com

    https://www.fiercebiotech.com/biotech/magentas-c-suite-heads-out-door-85-staff-closing-process-gets-underway

    WebFeb 9, 2023 · Last week, Magenta Therapeutics announced plans to close down. This week, executive leadership and staff are being handed their pink slips. The stem cell transplant biotech is cutting 56...

    DA: 41 PA: 52 MOZ Rank: 22

  • Magenta Therapeutics Announces Positive Preliminary Results …

    businesswire.com

    https://www.businesswire.com/news/home/20210512005561/en/Magenta-Therapeutics-Announces-Positive-Preliminary-Results-from-Phase-2-Clinical-Trial-of-MGTA-145-in-Multiple-Myeloma-and-Provides-an-Update-on-its-Anticipated-Clinical-Study-with-MGTA-117

    WebMay 12, 2021 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants...

    DA: 45 PA: 37 MOZ Rank: 41

  • Magenta Therapeutics and Dianthus Therapeutics Announce …

    yahoo.com

    https://finance.yahoo.com/news/magenta-therapeutics-dianthus-therapeutics-announce-110000570.html

    WebCAMBRIDGE, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- Magenta Therapeutics, Inc. (Nasdaq: MGTA) (“Magenta”) and Dianthus Therapeutics, Inc. (“Dianthus”), a privately-held, clinical-stage...

    DA: 79 PA: 92 MOZ Rank: 60

  • Magenta Therapeutics Presents Final Phase 1 Results of MGTA …

    businesswire.com

    https://www.businesswire.com/news/home/20210315005201/en/Magenta-Therapeutics-Presents-Final-Phase-1-Results-of-MGTA-145-Stem-Cell-Mobilization-Clinical-Trial-and-Preclinical-Data-from-Targeted-Conditioning-Program-at-the-European-Society-for-Blood-and-Marrow-Transplantation-EBMT-2021-Annual-Meeting

    WebMar 15, 2021 · Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with blood...

    DA: 24 PA: 2 MOZ Rank: 53

  • Magenta Therapeutics Announces IND Clearance for MGTA-117 …

    businesswire.com

    https://www.businesswire.com/news/home/20210915005365/en/Magenta-Therapeutics-Announces-IND-Clearance-for-MGTA-117-Targeted-Conditioning-Clinical-Trial

    WebSep 15, 2021 · Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplants to more patients with blood cancers, genetic diseases...

    DA: 69 PA: 78 MOZ Rank: 20

  • Magenta Therapeutics Presents Positive MGTA-117 Clinical

    globenewswire.com

    https://www.globenewswire.com/news-release/2022/12/12/2572282/0/en/Magenta-Therapeutics-Presents-Positive-MGTA-117-Clinical-Data-at-the-American-Society-of-Hematology-ASH-Annual-Meeting-and-Provides-Program-Updates.html

    WebCAMBRIDGE, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines designed to bring the curative power...

    DA: 12 PA: 80 MOZ Rank: 23

  • Magenta Therapeutics Provides Update for MGTA-117 Phase 1/2

    globenewswire.com

    https://www.globenewswire.com/en/news-release/2022/12/20/2577128/0/en/Magenta-Therapeutics-Provides-Update-for-MGTA-117-Phase-1-2-Dose-Escalation-Clinical-Trial.html

    WebDec 20, 2022 · About Magenta Therapeutics. Magenta Therapeutics is a clinical-stage biotechnology company developing medicines designed to bring the curative power of stem cell transplant to more patients...

    DA: 42 PA: 17 MOZ Rank: 60